Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of ITCI will rise by +0.26% over the next 2 Weeks and hit $132.21 by Tuesday, April 15, 2025. In that time frame, ITCI's share price is expected to range between $123.00 and $141.33.
BearishAverageBullishITCI shares remained flat 0 in Wednesday, April 2, 2025's trading session, starting and closing at a previous close of $131.87 to move at $131.87. The stock demonstrated notable intraday movement (see ITCI's key stats for a full breakdown), fluctuating between $131.87 and $131.87, a 0 trading range. While recent weeks have seen some volatility, ITCI has managed to secure a +0.26% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 15.53M shares changing hands, 12.98M more than the previous session. This amounted to $2.05B in total market activity.
Will ITCI Continue Its Upward Trend?
According to analyst ratings and projections for ITCI, Intra-Cellular Therapies, Inc. shares are anticipated to increase by +7.11%, potentially reaching $141.97 per share by April 15, 2025. Short-term technical indicators currently suggest a neutral sentiment for ITCI. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the ITCI stock forecast, now is a good time to buy ITCI stock because its current trading price is -0.28% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ITCI covering social and institutional perspectives.
ITCI Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into ITCI's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 82.75% to 84.54%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 74.34%, indicates significant medium-term strength. However, the 100-day RSI, at 67.16%, points to growing bullish momentum over the long term. Insights into ITCI's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Intra-Cellular Therapies Short-Term Forecasts
ITCI Forecast For Next 5 Days
Our algorithm anticipates Intra-Cellular Therapies (ITCI) stock could hit $134.55 by Apr 18, 2025. This represents a +2.03% rise from today's price, following a +0.13% change over the past five days.
ITCI Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Intra-Cellular Therapies, Inc. (ITCI) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $133.70, which would mean a +1.39% increase from the current price of $131.87. Projections for this period range from a high of $143.05 to a low of $124.51.
ITCI Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Intra-Cellular Therapies's price over the next three months point to a drop. ITCI stock is expected to peak at $113.39 on Mar 06, 2026 after potentially dipping to $95.82 on Feb 03, 2026. On average, ITCI is likely to trade around $105.43 in the coming 90 days.
Intra-Cellular Therapies Stock Forecast 2025
Based on our predictive models, Intra-Cellular Therapies (ITCI) is expected to trade between $82.20 and $116.25 throughout 2025. This would result in an average price of $98.85, potentially offering investors a -25.04% return from current levels.
Intra-Cellular Therapies, Inc. Monthly Forecast 2025–2026
April 2025
According to our latest forecast models, Intra-Cellular Therapies, Inc. (ITCI) is positioned to show a strong performance in April 2025. The price is predicted to move between $82.20 and $96.70, settling at an average of $89.64. This could translate to a -32.02% loss.
May 2025
Based on current market signals, Intra-Cellular Therapies, Inc. is projected to trend may 2025. We forecast a trading range from $85.42 to $100.96, with a likely average price of $93.53. Investors could expect a potential return of -29.07%.
June 2025
Our predictive algorithms indicate Intra-Cellular Therapies, Inc. stock may see a shift in June 2025. The expected range spans $87.32–$105.11, with an average target of $96.69. This represents a cautious outlook and a possible loss of -26.68%.
July 2025
Analyzing established trends, Intra-Cellular Therapies, Inc. looks set to move in July 2025. Projections place the stock between $94.03 and $106.34, averaging around $100.06. This suggests a -24.12% loss from current levels.
August 2025
Market indicators suggest Intra-Cellular Therapies, Inc. could experience notable changes during August 2025. Prices could fluctuate within $93.35 to $106.81, with a midpoint forecast of $99.42. The stock might deliver a -24.61% loss.
September 2025
Forecasting for September 2025, models estimate that Intra-Cellular Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $88.46 and $103.15, averaging $96.43. This signals a cautious trajectory with potential returns around -26.87%.
October 2025
According to our latest forecast models, Intra-Cellular Therapies, Inc. (ITCI) is positioned to show a strong performance in October 2025. The price is predicted to move between $84.48 and $107.32, settling at an average of $99.91. This could translate to a -24.24% loss.
November 2025
Based on current market signals, Intra-Cellular Therapies, Inc. is projected to trend november 2025. We forecast a trading range from $94.44 to $116.25, with a likely average price of $104.67. Investors could expect a potential return of -20.63%.
December 2025
Our predictive algorithms indicate Intra-Cellular Therapies, Inc. stock may see a shift in December 2025. The expected range spans $101.04–$112.57, with an average target of $106.74. This represents a cautious outlook and a possible loss of -19.06%.
January 2026
Analyzing established trends, Intra-Cellular Therapies, Inc. looks set to move in January 2026. Projections place the stock between $97.52 and $112.91, averaging around $105.81. This suggests a -19.76% loss from current levels.
February 2026
Market indicators suggest Intra-Cellular Therapies, Inc. could experience notable changes during February 2026. Prices could fluctuate within $95.82 to $110.71, with a midpoint forecast of $103.24. The stock might deliver a -21.71% loss.
March 2026
Forecasting for March 2026, models estimate that Intra-Cellular Therapies, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $100.59 and $113.57, averaging $107.25. This signals a cautious trajectory with potential returns around -18.67%.
April 2026
According to our latest forecast models, Intra-Cellular Therapies, Inc. (ITCI) is positioned to show a strong performance in April 2026. The price is predicted to move between $101.55 and $110.40, settling at an average of $106.03. This could translate to a -19.60% loss.
ITCI's history of dividends and stock splits also plays a role in long-term investor confidence.